{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:52:43Z","timestamp":1788537163541,"version":"build-2803163510"},"reference-count":182,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since the terrorist attack of September 11, 2001, preparation by the health care system for an act of terrorism has been mandated by leaders of governments. Scenarios for terrorist acts involving radioactive material have been identified, and approaches to management (based on past experience from atomic weapons detonations and radiation accidents) have been developed. Because of their experience in managing patients with profound cytopenia and\/or marrow aplasia, hematologists will be asked to play a significant role in evaluating and treating victims of mass accidental or deliberate exposure to radiation. This review provides a framework for understanding how radiation levels are quantified, how radiation alters the function of hematopoietic (and nonhematopoietic) cells and tissues, and how victims receiving a significant radiation dose can be identified and managed.<\/jats:p><jats:p>In Section I, Dr. Nicholas Dainiak reviews four components of the Acute Radiation Syndrome: the hematopoietic, neurovascular, gastrointestinal and cutaneous subsyndromes. Clinical signs and symptoms are discussed for exposed individuals at the time of initial presentation (the prodromal phase) and during their course of disease (the manifest illness). In Section II, he presents clinical and laboratory methods to assess radiation doses, including time to onset and severity of vomiting, rate of decline in absolute blood lymphocyte count and the appearance of chromosome aberrations such as dicentrics and ring forms. Potential scenarios of a radiation terrorist event are reviewed, and methods for initial clinical assessment, triage, and early management of the acute radiation syndrome and its component subsyndromes are summarized.<\/jats:p><jats:p>In Section III, Dr. Jamie Waselenko reviews the hematopoietic syndrome, and presents guidelines for the use of cytokine therapy, antibiotics, and supportive care that have been developed by the Strategic National Pharmaceutical Stockpile Working Group. Results of preclinical and clinical growth factor therapy studies with G-CSF, GM-CSF, pegylated G-CSF, SCF, and IL-3 are summarized. When and how potassium iodide should be used after exposure to radioiodines is also reviewed.<\/jats:p><jats:p>In Section IV, Dr. James Armitage describes a narrow \u201cwindow\u201d of 7 to 10 Gy where therapy with stem cell transplantation may be appropriate. Victims who are candidates for allotransplantation should not have major trauma or significant injury to other (nonhematopoietic) tissues. Rarely, victims may have an identical sibling or autologous stored marrow or blood stem cells, in which case the threshold for transplantation is 4 Gy.<\/jats:p><jats:p>In Section V, Dr. Thomas MacVittie describes new directions for therapy, using cytokines such as IL-7, keratinocyte growth factor, and FLT-3. The potential for combinations of cytokines to enhance hematopoietic recovery is also reviewed.<\/jats:p>","DOI":"10.1182\/asheducation-2003.1.473","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T22:16:55Z","timestamp":1069712215000},"page":"473-496","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":177,"title":["The Hematologist and Radiation Casualties"],"prefix":"10.1182","volume":"2003","author":[{"given":"Nicholas","family":"Dainiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Waselenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"MacVittie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Farese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021220435796100_R1","unstructured":"Hall EJ. Radiobiology for the Radiologist. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2000."},{"key":"2020021220435796100_R2","unstructured":"National Research Council, Committee on the Biological effects of Ionizing Radiation. Health Effects of Exposure to Low Levels of Ionizing Radiation, BEIR V. Washington, DC: National Academy Press; 1990."},{"key":"2020021220435796100_R3","unstructured":"Chinsoo Cho L, Glatstein E. Radiation Injury. In: AS Fauci, E Braunwald, KL Isselbacher, et al, eds. Harrison\u2019s Principles of Internal Medicine. New York, NY: McGraw-Hill; 1998:2559."},{"key":"2020021220435796100_R4","unstructured":"Ricks RC. The radiation-accident patient in the new millennium: past history and future threats. In: RC Ricks, ME Berger, FM O\u2019Hara, eds. The Medical Bases for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: The Parthenon Publishing Group; 2002:1."},{"key":"2020021220435796100_R5","doi-asserted-by":"crossref","unstructured":"Fliedner TM, Cronkite EP, Bond VP, eds. Stem Cells. 1995;(suppl 1):13.","DOI":"10.1002\/stem.5530130702"},{"key":"2020021220435796100_R6","unstructured":"Fliedner TM, Feinendergen LE, Hopewell JW. Chronic irradiation: tolerance and failure in complex biological systems. Br J Radiol. 2002;(suppl 26)"},{"key":"2020021220435796100_R7","unstructured":"Fliedner TM, Meineke V, Dainiak N, Gourmelon P, Akashi M. Radiation-Induced Multi-Organ Involvement and Failure: A Challenge for Pathogenetic, Diagnostic and Therapeutic Approaches and Research. Ulm, Germany, November 2003. British Insitute of Radiology. In press."},{"key":"2020021220435796100_R8","unstructured":"Dainiak N, Schull WJ, Karkanitsa L, Aleinikova OA, eds. Radiation injury and the Chernobyl catastrophe. Stem Cells. 1997;15(suppl 2):31."},{"key":"2020021220435796100_R9","unstructured":"Karaoglou A, Desmet G, Kelly GN, Menzel HG, eds. The Radiological Consequences of the Chernobyl Accident. Luxembourg: Office of the European Communities; 1996."},{"key":"2020021220435796100_R10","unstructured":"Lushbaugh CC. Human radiation tolerance. In: Parker J Jr, ed. Bioastronautics Data Book. NASA-S-30006. Washington, DC: National Aeronotics and Space Administration; 1973:421."},{"key":"2020021220435796100_R11","unstructured":"Wald N. Radiation Injury. In: Wyngaarden JB, Smith LH Jr, eds. Cecil Textbook of Medicine. Philadelphia, PA: W.B. Saunders; 1982:2228."},{"key":"2020021220435796100_R12","doi-asserted-by":"crossref","unstructured":"Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5\u201330Gy. Health Phys. 1989;56:821.","DOI":"10.1097\/00004032-198906000-00001"},{"key":"2020021220435796100_R13","unstructured":"Fliedner TM, Friesecke I, Beyrer K. Medical Management of Radiation Accidents: Manual on the Acute Radiation Syndrome. British Inst Radiol. Oxford; 2001."},{"key":"2020021220435796100_R14","unstructured":"Gangloff H. Hippocampal spike activity following low doses of irradiation. In: Haley TJ, Snider RS, eds. Response of the Nervous System to Ionizing Radiation. Boston, MA: Little Brown; 1964:221."},{"key":"2020021220435796100_R15","doi-asserted-by":"crossref","unstructured":"Husebye E, Hauer-Jensen M, Kjorstad K, Skar V. Severe late radiation enteropathy is characterized by impaired motility of the proximal small intestine. Dig Dis Sci. 1994;39:2341.","DOI":"10.1007\/BF02087648"},{"key":"2020021220435796100_R16","doi-asserted-by":"crossref","unstructured":"Goans RE, Holloway EC, Berger ME, Ricks, RC. Early dose assessment in criticality accidents. Health Phys. 2001;81:446.","DOI":"10.1097\/00004032-200110000-00009"},{"key":"2020021220435796100_R17","doi-asserted-by":"crossref","unstructured":"Andrews GA, Auxier JA, Lushbaugh CC. The importance of dosimetry to the medical management of persons accidentally exposed to high levels of radiation. In: Personnel Dosimetry for Radiation Accidents. Vienna, Austria: IAEA, Vienna; 1965:3.","DOI":"10.2172\/4606717"},{"key":"2020021220435796100_R18","doi-asserted-by":"crossref","unstructured":"Andrews GA, Cloutier RJ. Accidental acute radiation injury. Arch Environ Health. 1965;10:498.","DOI":"10.1080\/00039896.1965.10664034"},{"key":"2020021220435796100_R19","doi-asserted-by":"crossref","unstructured":"Albanese J, Dainiak N. Ionizing radiation alters Fas ligand at the surface and as exfoliated plasma membrane-derived vesicles. Radiat Res. 2000;153:49.","DOI":"10.1667\/0033-7587(2000)153[0049:IRAFAL]2.0.CO;2"},{"key":"2020021220435796100_R20","unstructured":"Stodtmeister R, Sandkuhler S, Fliedner TM. Uber die pathogenese akuter knochenmarkatrophie bei ratten nach ganzkorperbestrahlung mit schnellen elektronen. Folia Haematologica. 1956;3:303."},{"key":"2020021220435796100_R21","doi-asserted-by":"crossref","unstructured":"Fliedner TM, Tibken B, Hofer EP, Paul W. Stem cell response after radiation exposure: a key to the evaluation and prediction of its effects. Health Phys. 1996;70:787.","DOI":"10.1097\/00004032-199606000-00002"},{"key":"2020021220435796100_R22","doi-asserted-by":"crossref","unstructured":"Rezvani M, Hopewell JW, Wilkinson J, Bray S, Charles M. Time and dose-related changes in the thickness of skin in the pig after irradiation with single doses of 170Tm B-rays. Radiat Res. 2000;153:104.","DOI":"10.1667\/0033-7587(2000)153[0104:TADRCI]2.0.CO;2"},{"key":"2020021220435796100_R23","unstructured":"Peter RU. Cutaneous radiation syndrome\u2014clinical and therapeutic aspects. Rad Protect Bull. 1996;183:19"},{"key":"2020021220435796100_R24","unstructured":"Gusev I, Guskova AK, Mettler Fa Jr., eds. Medical Management of Radiation Accidents, 2nd ed. Boca Raton, FL: CRC Press; 2001."},{"key":"2020021220435796100_R25","unstructured":"Rotblat J. Acute mortality in nuclear war. In: Soloman F, Marston RQ, eds. The Medical Implications of Nuclear War. Washington, DC: Institute of Medicine, National Academy of Sciences; 1986."},{"key":"2020021220435796100_R26","doi-asserted-by":"crossref","unstructured":"Mole RH. The Ld50 for uniform low LET irradiation in man. Br J Radiol. 1984;57:355.","DOI":"10.1259\/0007-1285-57-677-355"},{"key":"2020021220435796100_R27","doi-asserted-by":"crossref","unstructured":"Lushbaugh CC. Reflections on some recent progress in human radiobiology. In: Augenstein LC, Mason R, Zelle M, eds. Advances in Radiation Biology. New York, NY: Academic Press; 1969:277","DOI":"10.1016\/B978-1-4832-3122-8.50012-3"},{"key":"2020021220435796100_R28","doi-asserted-by":"crossref","unstructured":"Vriesendorp HM, Van Bekkum DW. Susceptibility to total-body irradiation. In: Broerse JJ, MacVittie T, eds. Response to Total-BodyIrradiation in Different Species. Amsterdam: Martinus Nijhoff; 1984.","DOI":"10.1007\/978-94-009-6048-0_4"},{"key":"2020021220435796100_R29","doi-asserted-by":"crossref","unstructured":"Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30:513.","DOI":"10.1016\/S0301-472X(02)00802-0"},{"key":"2020021220435796100_R30","unstructured":"Management of terrorist events involving radioactive material. NCRP Report No. 138. Bethesda, MD: National Council on Radiation Protection and Measurements; 2001."},{"key":"2020021220435796100_R31","unstructured":"Second General Accounting Office Report on Sealed Radioactive Sources. June 16, 2003."},{"key":"2020021220435796100_R32","doi-asserted-by":"crossref","unstructured":"Mettler FA, Voelz GL. Major radiation exposure: What to expect and how to respond. N Engl J Med. 2002;346:1554\u20131561.","DOI":"10.1056\/NEJMra000365"},{"key":"2020021220435796100_R33","unstructured":"Shigematsu I, Ito C, Kamada N, Akiyama M, Sasaki H. A-Bomb Radiation Effects Digest: Bunkodo Co., Ltd., Toyko and Harwood Academic Publishers, Chur; 1993."},{"key":"2020021220435796100_R34","unstructured":"Bouville A, Anspaugh L, Beebe GQ. What is desirable and feasible in dose reconstruction for application in epidemiological studies? In: A Karaglou, G Desmetg, GN Kelly, et al, eds. The Radiological Consequences of the Chernobyl Accident. Luxembourg: Office for Official Public of the European Communities; 1996: 995."},{"key":"2020021220435796100_R35","doi-asserted-by":"crossref","unstructured":"Brooks AL. Biomarkers of exposure, sensitivity and disease. Int J Radiat Biol1999;75:1481\u20131503.","DOI":"10.1080\/095530099139106"},{"key":"2020021220435796100_R36","doi-asserted-by":"crossref","unstructured":"Bender MA, Gooch PC. Somatic chromosome aberrations induced by human whole-body irradiation: the \u201cRecuplex\u201d criticality accident. Radiat Res. 1966;29:568.","DOI":"10.2307\/3572080"},{"key":"2020021220435796100_R37","unstructured":"Bender MA. Cytogenetics research in radiation biology. Stem Cells. 1995;13(suppl 1):172."},{"key":"2020021220435796100_R38","doi-asserted-by":"crossref","unstructured":"Kolanko CJ, Pyle MD, Nath J, Prasanna PGS, Loats H, Blakely WF. In situ detection of a PCR-synthesized human pancentromeric DNA hybridization probe by color pigment immunostaining: application for dicentric assay automation. Biotech Histochem. 2000;75:91.","DOI":"10.3109\/10520290009064153"},{"key":"2020021220435796100_R39","doi-asserted-by":"crossref","unstructured":"Pantelias, GE, Mallie HD. Direct analysis of radiation-induced chromosome fragments and rings in unstimulated human peripheral blood lymphocytes by means of the premature chromosome consideration technique. Mutat Res1985;149:67.","DOI":"10.1016\/0027-5107(85)90010-7"},{"key":"2020021220435796100_R40","doi-asserted-by":"crossref","unstructured":"Lloyd DC, Edwards AA, Moquet JE, Guerrero-Carbajal YC. The role of cytogenetics in early triage of radiation casualties. Appl Rad Isotopes. 2000;52:1107\u20131112.","DOI":"10.1016\/S0969-8043(00)00054-3"},{"key":"2020021220435796100_R41","doi-asserted-by":"crossref","unstructured":"Prassanna PGS, Escalada ND, Blakely WF. Induction of premature chromosome condensation by a phosphatase inhibitor and a protein kinase in unstimulated human peripheral blood lymphocytes: a simple and rapid technique to study chromosome aberrations using specific whole-chromosome DNA hybridization probes for biological dosimetry. Mutat Res. 2000;466:131.","DOI":"10.1016\/S1383-5718(00)00011-5"},{"key":"2020021220435796100_R42","doi-asserted-by":"crossref","unstructured":"Goans RE, Holloway EC, Berger ME, Ricks, RC. Early dose assessment following severe radiation accidents. Health Phys. 1997;72:513.","DOI":"10.1097\/00004032-199704000-00001"},{"key":"2020021220435796100_R43","unstructured":"Wald N. Diagnosis and therapy of radiation injuries. Bull N Y Acad Med. 1983;59:1129."},{"key":"2020021220435796100_R44","unstructured":"Hartmann A, Bojar H, Zamboglou N, Pape Hm, Schnabel T, Schmitt G. The significance of clinical prodromes for dosage estimation after whole-body radiation exposure. Strahleuther Onkol. 1994;170:538."},{"key":"2020021220435796100_R45","unstructured":"Gottlober P, Krahn G, Peter RU. Cutaneous radiation syndrome: clinical features, diagnosis and therapy. Hautarzt. 2000;51:567."},{"key":"2020021220435796100_R46","unstructured":"Goans RE. Clincal care of the radiation-accident patient: patient presentation, assessment and initial diagnosis. In: Ricks RC, Berger ME, O\u2019Hara FM, eds. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: Partheon Publishing Grp; 2002:11."},{"key":"2020021220435796100_R47","unstructured":"Management of Persons Accidentally Contaminated with Radionuclides. NCRP Report No. 65, Bethesda, MD: National Council on Radiation Protection and Measurements; 1979."},{"key":"2020021220435796100_R48","doi-asserted-by":"crossref","unstructured":"Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30:513.","DOI":"10.1016\/S0301-472X(02)00802-0"},{"key":"2020021220435796100_R49","doi-asserted-by":"crossref","unstructured":"McCulloch EA, Till JE. The sensitivity of cells from normal mouse bone marrow to radiation in vitro and in vivo. Radiat Res. 1962;16:822.","DOI":"10.2307\/3571281"},{"key":"2020021220435796100_R50","doi-asserted-by":"crossref","unstructured":"VanBekhum DW. Radiation sensitivity of the hematopoietic stem cell. Radiat Res. 1991;128:S4.","DOI":"10.2307\/3577994"},{"key":"2020021220435796100_R51","unstructured":"Inoue T, Hirabayashai Y, Mitsui H, et al. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction. Exp Hematol. 1995;23:1296."},{"key":"2020021220435796100_R52","doi-asserted-by":"crossref","unstructured":"Amundson SA, Bittner M, Meltzer P, et al. Physiological function of large transcription programs: the cellular response to stress. Comp Biochem Physiol Biochem Mol Biol. 2001;129:703.","DOI":"10.1016\/S1096-4959(01)00389-X"},{"key":"2020021220435796100_R53","doi-asserted-by":"crossref","unstructured":"Amundson SA, Do KT, Shahab S, et al. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res. 2000;154:342.","DOI":"10.1667\/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2"},{"key":"2020021220435796100_R54","unstructured":"Schreyer SK, Karkanitsa LV, Albanese J, Ostapenko VA, Shevchuk VY, Dainiak N. Analysis of radiation-associated changes in gene expression using microarray technology. Br J Radiol. 2002;26(suppl):131."},{"key":"2020021220435796100_R55","unstructured":"Amundson SA, Fornace AJ. Gene expression profiles for monitoring radiation exposure. Radiat Prot Dosimetry. 2001;1997:11."},{"key":"2020021220435796100_R56","unstructured":"The federal response plan: FEMA 229. Washington, DC. Federal Emergency Medical Agency; 1999."},{"key":"2020021220435796100_R57","unstructured":"Weapons of mass destruction incident contingency plan. Washington, DC: Federal Bureau of Investigation, 1998."},{"key":"2020021220435796100_R58","doi-asserted-by":"crossref","unstructured":"Sin RC, et al. Biodosimetry assessment tool: a post-exposure software application for management of radiation accidents. Mil Med. 2001;166 (suppl 12):85.","DOI":"10.1093\/milmed\/166.suppl_2.85"},{"key":"2020021220435796100_R59","doi-asserted-by":"crossref","unstructured":"Becker SM. Psychosocial assistance after environmental accidents: a policy perspective. Environ Health Perspect. 1997;105 (suppl 6):1557.","DOI":"10.1289\/ehp.97105s61557"},{"key":"2020021220435796100_R60","unstructured":"Mental Health and Mass Violence, Evidence-Based Early Psychological Intervention for Victims\/Survivors of Mass Violence. NIH Pub. 02-5138. Washington, DC: National Institute of Mental Health Workshop; 2002."},{"key":"2020021220435796100_R61","unstructured":"Hall EJ. Acute effects of total-body irradiation. In: Hall EJ, ed. Radiobiology for the Radiologist. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:124\u2013135."},{"key":"2020021220435796100_R62","unstructured":"Walker RL, Cerveny TJ. Textbook of Military Medicine: Medical consequences of nuclear warfare. Falls Church, VA: Office of the Surgeon General; 1989."},{"key":"2020021220435796100_R63","doi-asserted-by":"crossref","unstructured":"van Bekkum D. Radiation sensitivity of the hematopoietic stem cell. Radiat Res. 1991;128:S4\u20139.","DOI":"10.2307\/3577994"},{"key":"2020021220435796100_R64","unstructured":"Inouet T, Hirabayashai Y, Mitsui H, et al. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radiosensitive subfraction. Exp Hematol. 1995;23:1296\u20131300."},{"key":"2020021220435796100_R65","doi-asserted-by":"crossref","unstructured":"Vorobiev AI. Acute radiation disease and biological dosimetry in 1993. Stem Cells. 1997;15 Suppl 2:269\u2013274.","DOI":"10.1002\/stem.5530150736"},{"key":"2020021220435796100_R66","doi-asserted-by":"crossref","unstructured":"Goans RE, Holloway EC, Berger ME, et al. Early dose assessment following severe radiation accidents. Health Phys. 1997;72:513\u2013518.","DOI":"10.1097\/00004032-199704000-00001"},{"key":"2020021220435796100_R67","unstructured":"Baranov AE, Guskova AK, Nadejina NM, et al. Chernobyl experience: biological indicators of exposure to ionizing radiation. Stem Cells. 1995;13 Suppl 1:69\u201377."},{"key":"2020021220435796100_R68","doi-asserted-by":"crossref","unstructured":"Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns. 1994;20:487\u2013490.","DOI":"10.1016\/0305-4179(94)90002-7"},{"key":"2020021220435796100_R69","doi-asserted-by":"crossref","unstructured":"Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC. Lymphocyte subset responses to trauma and sepsis. J Trauma.1993;35:844\u2013890.","DOI":"10.1097\/00005373-199312000-00007"},{"key":"2020021220435796100_R70","unstructured":"Lebedev MY, Sholkina MN, Utkina TM, et al. Immunophenotype of peripheral blood lymphocytes in patients with burns. Russ J Immunol. 2001;6:47\u201354."},{"key":"2020021220435796100_R71","unstructured":"Schull WJ. Effects of atomic radiation: a half-century of studies from Hiroshima and Nagasaki. John Wiley and Sons; 1995."},{"key":"2020021220435796100_R72","unstructured":"Barabanova AV. Acute radiation syndrome with cutaneous syndrome. In: Ricks RC, Berger ME, O\u2019Hara F, eds. The medical basis for radiation accident preparedness: the clinical care of victims. New York, NY: Partheneon; 2002:217\u2013224."},{"key":"2020021220435796100_R73","doi-asserted-by":"crossref","unstructured":"Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730\u2013751.","DOI":"10.1086\/339215"},{"key":"2020021220435796100_R74","doi-asserted-by":"crossref","unstructured":"Weisbart RH, Gasson JC, Golde DW. Colony-stimulating factors and host defense. Ann Intern Med. 1989;110:297\u2013303.","DOI":"10.7326\/0003-4819-110-4-297"},{"key":"2020021220435796100_R75","doi-asserted-by":"crossref","unstructured":"Mayer P, Schntze E, Lam C, Kricek F, Liehl E. Recombinant murine granulocyte macrophage colony-stimulating factor augments recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis. 1991;163:584\u2013590.","DOI":"10.1093\/infdis\/163.3.584"},{"key":"2020021220435796100_R76","doi-asserted-by":"crossref","unstructured":"Schiffer CA. Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia. Blood. 1996;88:3675\u20133685.","DOI":"10.1182\/blood.V88.10.3675.bloodjournal88103675"},{"key":"2020021220435796100_R77","doi-asserted-by":"crossref","unstructured":"Nemunaitis J, Rabinovil SN, Sunger JW, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med. 1991:324;1773\u20131778.","DOI":"10.1056\/NEJM199106203242504"},{"key":"2020021220435796100_R78","doi-asserted-by":"crossref","unstructured":"Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, MacDonald JS. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol. 1995;13:1323\u20131327.","DOI":"10.1200\/JCO.1995.13.6.1323"},{"key":"2020021220435796100_R79","doi-asserted-by":"crossref","unstructured":"Ciernik IF, Schanz U, Gmur J. Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: a prospective randomized trial. Bone Marrow Transplant. 1999;24:147\u2013151.","DOI":"10.1038\/sj.bmt.1701872"},{"key":"2020021220435796100_R80","doi-asserted-by":"crossref","unstructured":"Demirer T, Ayli M, Dagli M, et al. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation. Br J Haematol. 2002;118:1104\u20131111.","DOI":"10.1046\/j.1365-2141.2002.03762.x"},{"key":"2020021220435796100_R81","doi-asserted-by":"crossref","unstructured":"Bence-Bruckler I, Bredeson C, Atkins H, et al. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation. Bone Marrow Transplant. 1998;22:965\u2013969.","DOI":"10.1038\/sj.bmt.1701469"},{"key":"2020021220435796100_R82","unstructured":"Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 1997;25:1084\u20131093."},{"key":"2020021220435796100_R83","doi-asserted-by":"crossref","unstructured":"Farese AM, Hunt P, Grab LB, MacVittie TJ. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 1996;97:2145\u20132151.","DOI":"10.1172\/JCI118652"},{"key":"2020021220435796100_R84","doi-asserted-by":"crossref","unstructured":"MacVittie TJ, Farese Am, Herodin F, Grab LB, Baum CM, McKearn JP. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. Blood. 1996;87:4129\u20134135.","DOI":"10.1182\/blood.V87.10.4129.bloodjournal87104129"},{"key":"2020021220435796100_R85","doi-asserted-by":"crossref","unstructured":"Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte\/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood. 1997;90:2565\u20132573.","DOI":"10.1182\/blood.V90.7.2565"},{"key":"2020021220435796100_R86","doi-asserted-by":"crossref","unstructured":"Farese AM, Williams DE, Seiler FR, MacVittie TJ. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood. 1993;82:3012\u20133018.","DOI":"10.1182\/blood.V82.10.3012.3012"},{"key":"2020021220435796100_R87","doi-asserted-by":"crossref","unstructured":"Schuening FG, Appelbaum FR, Deeg HJ, et al. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 1993;81:20\u201326.","DOI":"10.1182\/blood.V81.1.20.20"},{"key":"2020021220435796100_R88","doi-asserted-by":"crossref","unstructured":"Nash RA, Schuening FG, Seidel K, et al. Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 1994;83:1963\u20131970.","DOI":"10.1182\/blood.V83.7.1963.1963"},{"key":"2020021220435796100_R89","doi-asserted-by":"crossref","unstructured":"Schuening FG, Storb R, Goehle S, et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 1989;74:1308\u20131313.","DOI":"10.1182\/blood.V74.4.1308.bloodjournal7441308"},{"key":"2020021220435796100_R90","doi-asserted-by":"crossref","unstructured":"Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest. 1959;38:1689\u20131697.","DOI":"10.1172\/JCI103947"},{"key":"2020021220435796100_R91","doi-asserted-by":"crossref","unstructured":"Perman V, Cronkite EP, Bond VP, Sorensen DK. The regenerative ability of hemopoietic tissue following lethal x-irradiation in dogs. Blood. 1962;19:724\u2013737.","DOI":"10.1182\/blood.V19.6.724.724"},{"key":"2020021220435796100_R92","doi-asserted-by":"crossref","unstructured":"Sorensen DK, Bond VP, Cronkite EP, Perman V. An effective therapeutic regimen for the hemopoietic phase of the acute radiation syndrome in dogs. Radiation Res. 1960;13: 669\u2013685.","DOI":"10.2307\/3571030"},{"key":"2020021220435796100_R93","doi-asserted-by":"crossref","unstructured":"Kumar KS, Srinivasan V, Toles RE, Miner VL, Jackson WE, Seed TM. High-dose antibiotic therapy is superior to a 3-drug combination of prostanoids and lipid A derivative in protecting irradiated canines. J Radiat Res (Tokyo). 2002;43:361\u2013370.","DOI":"10.1269\/jrr.43.361"},{"key":"2020021220435796100_R94","doi-asserted-by":"crossref","unstructured":"MacVittie TJ, Monroy R, Vigneulle RM, Zeman GH, Jackson WE. The relative biological effectiveness of mixed fission-neutron-gamma radiation on the hematopoietic syndrome in the canine: effect of therapy on survival. Radiat Res. 1991;128(1 Suppl):S29\u201336.","DOI":"10.2307\/3577998"},{"key":"2020021220435796100_R95","doi-asserted-by":"crossref","unstructured":"Farese AM, Casey DB, Vigneulle RM, et al. A single dose of pegylated leridistim significantly improves neutrophil recovery in sublethally irradiated rhesus macaques. Stem Cells. 2001;19:514\u2013521.","DOI":"10.1634\/stemcells.19-6-514"},{"key":"2020021220435796100_R96","unstructured":"Schlumberger HG, Vasquez JJ. Pathology of total body irradiation in the monkey. Am J Pathol. 1954;30:1013\u20131047."},{"key":"2020021220435796100_R97","unstructured":"Stanley RE, Seigneur LJ, Strike TA.. The acute mortality response of monkeys (Macacca mulatta) to mixed gamma-neutron radiations and 250 kVp X rays. SR66-23. Bethesda, MD: Armed Forces Radiobiology Research Institute; 1966."},{"key":"2020021220435796100_R98","doi-asserted-by":"crossref","unstructured":"Broerse JJ, van Bekkum DW, Hollander CF, Davids JA. Mortality of monkeys after exposure to fission neutrons and the effect of autologous bone marrow transplantation. Int J Radiat Biol Relat Stud Phys Chem Med. 1978;34:253\u2013264.","DOI":"10.1080\/09553007814550841"},{"key":"2020021220435796100_R99","doi-asserted-by":"crossref","unstructured":"Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002;9:389\u2013395.","DOI":"10.1097\/00045391-200209000-00005"},{"key":"2020021220435796100_R100","doi-asserted-by":"crossref","unstructured":"Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941\u20131949.","DOI":"10.1001\/jama.289.15.1941"},{"key":"2020021220435796100_R101","unstructured":"Narvios AB, Lichtiger B. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study. Haematologica. 2001;86:749\u2013752."},{"key":"2020021220435796100_R102","doi-asserted-by":"crossref","unstructured":"Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:712\u2013716.","DOI":"10.1067\/moe.2002.127585"},{"key":"2020021220435796100_R103","unstructured":"Redding SW. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis. NCI Monogr. 1990:103\u2013105."},{"key":"2020021220435796100_R104","doi-asserted-by":"crossref","unstructured":"Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study. J Infect Dis. 1995;171:1545\u20131552.","DOI":"10.1093\/infdis\/171.6.1545"},{"key":"2020021220435796100_R105","doi-asserted-by":"crossref","unstructured":"Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326:845\u2013851.","DOI":"10.1056\/NEJM199203263261301"},{"key":"2020021220435796100_R106","doi-asserted-by":"crossref","unstructured":"Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis. 1999;28:331\u2013340.","DOI":"10.1086\/515128"},{"key":"2020021220435796100_R107","doi-asserted-by":"crossref","unstructured":"Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis. 1995;172:1035\u20131041.","DOI":"10.1093\/infdis\/172.4.1035"},{"key":"2020021220435796100_R108","doi-asserted-by":"crossref","unstructured":"Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med. 1993;118:495\u2013503.","DOI":"10.7326\/0003-4819-118-7-199304010-00003"},{"key":"2020021220435796100_R109","doi-asserted-by":"crossref","unstructured":"Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730\u2013751.","DOI":"10.1086\/339215"},{"key":"2020021220435796100_R110","doi-asserted-by":"crossref","unstructured":"Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature. 1992;359:21.","DOI":"10.1038\/359021a0"},{"key":"2020021220435796100_R111","doi-asserted-by":"crossref","unstructured":"Brook I, Elliott TB, Ledney GD, Knudson GB. Management of postirradiation sepsis. Mil Med. 2002;167(2 Suppl):105\u2013106.","DOI":"10.1093\/milmed\/167.suppl_1.105"},{"key":"2020021220435796100_R112","doi-asserted-by":"crossref","unstructured":"Brook I, Ledney GD. Effect of antimicrobial therapy on the gastrointestinal bacterial flora, infection and mortality in mice exposed to different doses of irradiation. J Antimicrob Chemother. 1994;33(1):63\u201372.","DOI":"10.1093\/jac\/33.1.63"},{"key":"2020021220435796100_R113","doi-asserted-by":"crossref","unstructured":"Brook I, Elliott TB, Ledney GD. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin. Radiat Res. 1990;122:215\u20137.","DOI":"10.2307\/3577609"},{"key":"2020021220435796100_R114","doi-asserted-by":"crossref","unstructured":"Brook I, Ledney GD. Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation. J Antimicrob Chemother. 1994;33:777\u2013784.","DOI":"10.1093\/jac\/33.4.777"},{"key":"2020021220435796100_R115","doi-asserted-by":"crossref","unstructured":"Anonymous, International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment Center. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer: a trial of oral penicillin v or placebo combined with pefloxacin. JAMA. 1994; 272:1183\u20131189.","DOI":"10.1001\/jama.1994.03520150051036"},{"key":"2020021220435796100_R116","doi-asserted-by":"crossref","unstructured":"Engels EA, Ellis CA, Supran SE, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis. 1999;28:256\u2013266.","DOI":"10.1086\/515103"},{"key":"2020021220435796100_R117","doi-asserted-by":"crossref","unstructured":"Engels, E.A., J. Lau, and M. Barza, Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol.1998;16:1179\u20131187.","DOI":"10.1200\/JCO.1998.16.3.1179"},{"key":"2020021220435796100_R118","doi-asserted-by":"crossref","unstructured":"Murphy M, Brown AE, Sepkowitz KA, Bernard EM, Kiehn TE, Armstrong D. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer\u2014is it justified? Clin Infect Dis. 1997;25:346\u2013348.","DOI":"10.1086\/516925"},{"key":"2020021220435796100_R119","doi-asserted-by":"crossref","unstructured":"Bow EJ, Mandell LA, Louie TJ, et al. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented Gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group. Ann Intern Med. 1994;125:183\u2013190.","DOI":"10.7326\/0003-4819-125-3-199608010-00004"},{"key":"2020021220435796100_R120","doi-asserted-by":"crossref","unstructured":"Cruciani M, Rampazzo R, Malena M, et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis. 1996;23:346\u2013348.","DOI":"10.1093\/clinids\/23.4.795"},{"key":"2020021220435796100_R121","doi-asserted-by":"crossref","unstructured":"Osgood EE, Riddle MC, Matthews TJ. Aplastic anemia treated with daily transfusions and intravenous marrow; case report. Ann Intern Med. 1939;13:357\u2013367.","DOI":"10.7326\/0003-4819-13-2-357"},{"key":"2020021220435796100_R122","unstructured":"Lorenz E, Uphoff D, Reid TR, Shelton T. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst. 1951;12:197\u2013201."},{"key":"2020021220435796100_R123","doi-asserted-by":"crossref","unstructured":"Densow D, Kindler H, Baranov AE, Tibken B, Hofer EP, Fliedner TM. Criteria for the selection of radiation accident victims for stem cell transplantation. Stem Cells. 1997;15:287\u2013297.","DOI":"10.1002\/stem.5530150738"},{"key":"2020021220435796100_R124","doi-asserted-by":"crossref","unstructured":"Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994;84:2221\u20132228.","DOI":"10.1182\/blood.V84.7.2221.2221"},{"key":"2020021220435796100_R125","doi-asserted-by":"crossref","unstructured":"Mackall CL, Fleisher TA, Brown MR, et al. Distinctions between CD8+ and CD4+ T-cell regeneration pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 1997;89:3700\u20133707.","DOI":"10.1182\/blood.V89.10.3700"},{"key":"2020021220435796100_R126","doi-asserted-by":"crossref","unstructured":"Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96:2299\u20132303.","DOI":"10.1182\/blood.V96.6.2299"},{"key":"2020021220435796100_R127","doi-asserted-by":"crossref","unstructured":"Borge OJ, Adolfsson J, Martensson A, et al. Lymphoid-restricted development from multipotent candidate murine stem cells: Distinct and complimentary functions of the c-kit and flt3-ligands. Blood. 1999;94:3781\u20133790.","DOI":"10.1182\/blood.V94.11.3781"},{"key":"2020021220435796100_R128","doi-asserted-by":"crossref","unstructured":"Hirayama F, Aiba Y, Ikebuchi K, et al. Differentiation in culture of murine primitive lymphohematopoietic progenitors toward T-cell lineage. Blood. 1999;93:4187\u20134195.","DOI":"10.1182\/blood.V93.12.4187"},{"key":"2020021220435796100_R129","doi-asserted-by":"crossref","unstructured":"Sims JE, Williams DE, Morrissey PJ, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med. 2000;192:671\u2013680.","DOI":"10.1084\/jem.192.5.671"},{"key":"2020021220435796100_R130","doi-asserted-by":"crossref","unstructured":"Andrew D, Aspinall R. IL-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol. 2001;166:1524\u20131530.","DOI":"10.4049\/jimmunol.166.3.1524"},{"key":"2020021220435796100_R131","unstructured":"Friend SL, Hosier S, Nelson A, et al. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321\u2013328."},{"key":"2020021220435796100_R132","doi-asserted-by":"crossref","unstructured":"Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A. 2001;98:8732\u20138737.","DOI":"10.1073\/pnas.161126098"},{"key":"2020021220435796100_R133","doi-asserted-by":"crossref","unstructured":"Fry TJ, Connick E, Fallon J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood. 2001;97:2983\u20132990.","DOI":"10.1182\/blood.V97.10.2983"},{"key":"2020021220435796100_R134","doi-asserted-by":"crossref","unstructured":"Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 2001;22:564\u2013571.","DOI":"10.1016\/S1471-4906(01)02028-2"},{"key":"2020021220435796100_R135","doi-asserted-by":"crossref","unstructured":"Geiselhart LA, Humphries CA, Gregorio TA, et al. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol. 2001;166:3019\u20133027.","DOI":"10.4049\/jimmunol.166.5.3019"},{"key":"2020021220435796100_R136","doi-asserted-by":"crossref","unstructured":"von Freeden-Jeffry U, Vieira P, Lucian LA, et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181:1519\u20131526.","DOI":"10.1084\/jem.181.4.1519"},{"key":"2020021220435796100_R137","doi-asserted-by":"crossref","unstructured":"Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor deficient mice. J Exp Med. 1994;180:1955\u20131960.","DOI":"10.1084\/jem.180.5.1955"},{"key":"2020021220435796100_R138","unstructured":"Abdul-Hai A, Or R, Slavin S, et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol. 1996;24:1416\u20131422."},{"key":"2020021220435796100_R139","doi-asserted-by":"crossref","unstructured":"Morrissey PJ, Conlon P, Braddy S, et al. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol. 1991;146:1547\u20131552.","DOI":"10.4049\/jimmunol.146.5.1547"},{"key":"2020021220435796100_R140","doi-asserted-by":"crossref","unstructured":"Bolotin E, Smogorzewska M, Smith S, et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood. 1996;88:1887\u20131894.","DOI":"10.1182\/blood.V88.5.1887.1887"},{"key":"2020021220435796100_R141","doi-asserted-by":"crossref","unstructured":"Mackall CL, Fry TJ, Bare C, et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood. 2001;97:1491\u20131497.","DOI":"10.1182\/blood.V97.5.1491"},{"key":"2020021220435796100_R142","doi-asserted-by":"crossref","unstructured":"Faltynek CR, Wang S, Miller D, et al. Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of myeloid lineage. J Immunol. 1992;149(4):1276\u20131282.","DOI":"10.4049\/jimmunol.149.4.1276"},{"key":"2020021220435796100_R143","doi-asserted-by":"crossref","unstructured":"Damia G, Komschlies KL, Faltynek CR, et al. Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood. 1992;79:1121\u20131129.","DOI":"10.1182\/blood.V79.5.1121.1121"},{"key":"2020021220435796100_R144","doi-asserted-by":"crossref","unstructured":"Fry TJ, Christensen BL, Komschilies KL, et al. Interleukin-7 restores immunity in athymic T-cell depleted hosts. Blood. 2001;97:1525\u20131533.","DOI":"10.1182\/blood.V97.6.1525"},{"key":"2020021220435796100_R145","doi-asserted-by":"crossref","unstructured":"Alpdogan O, Schmaltz C, Muriglan SJ, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood. 2001;98:2256\u20132265.","DOI":"10.1182\/blood.V98.7.2256"},{"key":"2020021220435796100_R146","doi-asserted-by":"crossref","unstructured":"Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood. 2003;101:2294\u20132299.","DOI":"10.1182\/blood-2002-07-2297"},{"key":"2020021220435796100_R147","doi-asserted-by":"crossref","unstructured":"Storek J, Gillespy T, Lu H, et al. Interleukin-7 improves CD4 T cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood. 2003;101:4209\u20134218.","DOI":"10.1182\/blood-2002-08-2671"},{"key":"2020021220435796100_R148","doi-asserted-by":"crossref","unstructured":"Weinberg K, Blazer BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458\u20131466.","DOI":"10.1182\/blood.V97.5.1458"},{"key":"2020021220435796100_R149","doi-asserted-by":"crossref","unstructured":"Erickson M, Morkowski S, Lehar S, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood. 2002;100:3269\u20133278.","DOI":"10.1182\/blood-2002-04-1036"},{"key":"2020021220435796100_R150","doi-asserted-by":"crossref","unstructured":"Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 2002;99:4592\u20134600.","DOI":"10.1182\/blood.V99.12.4592"},{"key":"2020021220435796100_R151","doi-asserted-by":"crossref","unstructured":"Ornitz DM, Xu JS, Colvin DG, et al. Receptor specificity of the fibroblast growth-factor family. J Biol Chem. 1996;271:15292\u201315297.","DOI":"10.1074\/jbc.271.25.15292"},{"key":"2020021220435796100_R152","doi-asserted-by":"crossref","unstructured":"Revest JM, Suniara RK, Kerr K, et al. Development of the thymus requires signaling through the fibroblast growth factor receptor R2IIIb. J Immunol. 2001;167:1954\u20131961.","DOI":"10.4049\/jimmunol.167.4.1954"},{"key":"2020021220435796100_R153","unstructured":"Yi ES, Williams ST, Lee H, et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol. 1996;149:1963\u20131970."},{"key":"2020021220435796100_R154","unstructured":"Farrell CL, Bready JV, Rex KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 1998;58:933\u2013939."},{"key":"2020021220435796100_R155","doi-asserted-by":"crossref","unstructured":"Panoskaltsis-Mortari A, Lacey DL, Vallera DA, et al. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 1998;92:3960\u20133967.","DOI":"10.1182\/blood.V92.10.3960"},{"key":"2020021220435796100_R156","doi-asserted-by":"crossref","unstructured":"Panoskaltsis-Mortari A, Ingbar DH, Jung P, et al. KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT. Am J Physiol Lung Cell Mol Physiol. 2000;278:L988\u2013L999.","DOI":"10.1152\/ajplung.2000.278.5.L988"},{"key":"2020021220435796100_R157","doi-asserted-by":"crossref","unstructured":"Haddad IY, Panoskaltsis-Mortari A, Ingbar DH, et al. Interactions of keratinocyte growth factor with a nitrating species after arrow transplantation in mice. Am J Physiol Lung Cell Mol Physiol. 1999;277:L391\u2013L400.","DOI":"10.1152\/ajplung.1999.277.2.L391"},{"key":"2020021220435796100_R158","doi-asserted-by":"crossref","unstructured":"Panoskaltsis-Mortari A, Taylor PA, Rubin JS, et al. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury [abstract]. Blood. 2000;96:4350\u20134356.","DOI":"10.1182\/blood.V96.13.4350"},{"key":"2020021220435796100_R159","doi-asserted-by":"crossref","unstructured":"Lyman SD, Jacobsen SEW. c-kit ligand and flt3 ligand: Stem\/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101\u20131134.","DOI":"10.1182\/blood.V91.4.1101"},{"key":"2020021220435796100_R160","unstructured":"Berthro JM, Loilleux S, Chapel A, et al. CD135 (Flk2\/Flt3) expression by human thymocytes delineates a possible role of Flt3-ligand in T cell precursor proliferation and differentiation. Scand J Immunol. 2001;51:53\u201361."},{"key":"2020021220435796100_R161","doi-asserted-by":"crossref","unstructured":"Hirayama F, Lyman SD, Clark SC, et al. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood. 1995;85:1762\u20131768.","DOI":"10.1182\/blood.V85.7.1762.bloodjournal8571762"},{"key":"2020021220435796100_R162","unstructured":"Fry TJ, Sinhn M, Thomas EK, et al. Flt3 Ligand: a potential new immunorestorative agent [abstract]. Blood2001;98:735a."},{"key":"2020021220435796100_R163","doi-asserted-by":"crossref","unstructured":"Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T-cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609\u20134616.","DOI":"10.4049\/jimmunol.156.12.4609"},{"key":"2020021220435796100_R164","doi-asserted-by":"crossref","unstructured":"Rocha B, Boehmer H. Peripheral selection of the T cell repertoire. Science. 1991;251:1225\u20131228.","DOI":"10.1126\/science.1900951"},{"key":"2020021220435796100_R165","doi-asserted-by":"crossref","unstructured":"Streeter PR, Minster NI, Kahn LE, et al. Progenipoietins: Biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor. Exp Hematol. 2001;29:41\u201350.","DOI":"10.1016\/S0301-472X(00)00616-0"},{"key":"2020021220435796100_R166","unstructured":"MacVittie TJ, Farese AM, Lind LB, Smith WG, Streeter P, McKearn JP. Progenipoietin-G stimulates hematopoietic recovery following myelosuppression [abstract]. Blood. 1997;90:581a."},{"key":"2020021220435796100_R167","unstructured":"Farese AM, MacVittie TJ, Daquel L, Smith WG, Woulfe SL. Progenipoietins, chimeric agonists of FLT-3 and the G-CSF receptors, stimulate multilineage hematopoietic recovery in myelosuppressed nonhuman primates [abstract]. Blood. 1998;92:507s."},{"key":"2020021220435796100_R168","doi-asserted-by":"crossref","unstructured":"Herodin F, Bourin P, Mayol J-F, et al. Short-term injection of antiapoptotic cytokine combinations soon after lethal \u03b3-irradiation promotes survival. Blood. 2003;101:2609\u20132616.","DOI":"10.1182\/blood-2002-06-1634"},{"key":"2020021220435796100_R169","doi-asserted-by":"crossref","unstructured":"Lane DP. p53, Guardian of the genome. Nature. 1992;358:15\u201316.","DOI":"10.1038\/358015a0"},{"key":"2020021220435796100_R170","doi-asserted-by":"crossref","unstructured":"Wlodarski P, Wasik M, Ratajczak MZ, et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood. 1998;91:2998\u20133006.","DOI":"10.1182\/blood.V91.8.2998.2998_2998_3006"},{"key":"2020021220435796100_R171","unstructured":"Westfal CH, Hoyes KP, Canman CE, et al. Loss of atm Radiosensitizes multiple p53 null tissues. Cancer Res. 1998;58:5637\u20135639."},{"key":"2020021220435796100_R172","doi-asserted-by":"crossref","unstructured":"Westfal CH. atm and p53 cooperate in apoptosis and suppression of tumorgenesis, but not in resistance to acute radiation toxicity. Nat Genet. 1997;16:397\u2013401.","DOI":"10.1038\/ng0897-397"},{"key":"2020021220435796100_R173","doi-asserted-by":"crossref","unstructured":"Pestina TI, Cleveland JL, Yang C, et al. Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood. 2001;98:2084\u20132090.","DOI":"10.1182\/blood.V98.7.2084"},{"key":"2020021220435796100_R174","doi-asserted-by":"crossref","unstructured":"Mouthon M-A, Van der Meeren A, Gaugler M-H, et al. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Internatl J Radiat Oncol Biol Phys. 1999;43:867\u2013875.","DOI":"10.1016\/S0360-3016(98)00477-5"},{"key":"2020021220435796100_R175","doi-asserted-by":"crossref","unstructured":"Ritchie A, Vadhan-Raj S, Broxmeyer HE. Thrombopoetin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line. Stem Cells. 1996;14:330.","DOI":"10.1002\/stem.140330"},{"key":"2020021220435796100_R176","doi-asserted-by":"crossref","unstructured":"Ritchie A, Gotoh A, Gaddy J, et al. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: Potential mechanisms for survival enhancing effects. Blood. 1997;90:4394\u20134402.","DOI":"10.1182\/blood.V90.11.4394"},{"key":"2020021220435796100_R177","unstructured":"Furth FW, Coulter MP, Miller RW, et al. The treatment of acute radiation syndrome in dogs with auromycin and whole blood. J Lab Clin Med. 1953;41:918\u2013928."},{"key":"2020021220435796100_R178","doi-asserted-by":"crossref","unstructured":"MacVittie TJ, Monroy R, Vigneulle RM, et al. The relative biological effectiveness of mixed fission-neutron-radiation on the hematopoietic syndrome in the canine: Effect of therapy on survival. Radiat Res. 1991;128:529\u2013536.","DOI":"10.2307\/3577998"},{"key":"2020021220435796100_R179","doi-asserted-by":"crossref","unstructured":"Jackson DP, Sorensen DK, Cronkite EP, et al. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest. 1959;38:1689\u20131697.","DOI":"10.1172\/JCI103947"},{"key":"2020021220435796100_R180","doi-asserted-by":"crossref","unstructured":"Lowry PA, Deacon D, Whitefield P, et al. Stem cell factor induction of in vitro murine hematopoietic colony formation by \u201csubliminal\u201d cytokine combinations: the role of \u201canchor factors.\u201d Blood. 1992;80:663\u2013669.","DOI":"10.1182\/blood.V80.3.663.663"},{"key":"2020021220435796100_R181","doi-asserted-by":"crossref","unstructured":"Paul SR, Bennett F, Calvetti JA, et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A. 1990;87:7512\u20137516.","DOI":"10.1073\/pnas.87.19.7512"},{"key":"2020021220435796100_R182","doi-asserted-by":"crossref","unstructured":"Farese AM, Casey DB, Vigneulle RM, et al. A single dose of pegylated leridistim significantly improves neutrophil recovery in sublethally irradiated rhesus macaques. Stem Cells. 2001;19:514\u2013521.","DOI":"10.1634\/stemcells.19-6-514"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2003\/1\/473\/1713727\/473_496a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2003\/1\/473\/1713727\/473_496a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:33:20Z","timestamp":1682606000000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2003\/1\/473\/18671\/The-Hematologist-and-Radiation-Casualties"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":182,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2003.1.473","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}